With the investment, DIA is signaling that it believes Pearl can become a leader in the dental AI industry, according to a May 7 news release.
Pearl’s AI technology is FDA-approved and can help dentists increase efficiency, consistency and accuracy of their X-ray evaluations.
“DIA has been closely tracking the evolution of AI in dentistry, and our investment in Pearl underscores our commitment to supporting the most promising technologies that are redefining the future of dental care,” said Thomas Sharpe, DIA co-founder and managing partner.
